Dramatic response to alectinib in a patient with ALK‐rearranged squamous cell lung cancer

Lung cancers with anaplastic lymphoma kinase (ALK) rearrangements are highly sensitive to treatment with ALK tyrosine kinase inhibitors (TKIs). Due to the very low rate of patients with squamous cell carcinoma enrolled in clinical trials, the efficacy of ALK inhibitors in patients with ALK‐rearrange...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiihara, Jun, Ohyanagi, Fumiyoshi, Amari, Hikari, Toda, Minemichi, Tahara, Hiroki, Yuzawa, Motoi, Maeda, Yuki, Nomura, Motoko, Mizushina, Yoshiko, Nagai, Yoshiaki, Ohta, Hiromitsu, Yamaguchi, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410551/
https://www.ncbi.nlm.nih.gov/pubmed/34324792
http://dx.doi.org/10.1111/1759-7714.14092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410551/
https://www.ncbi.nlm.nih.gov/pubmed/34324792
http://dx.doi.org/10.1111/1759-7714.14092

Ejemplares similares